SCHEMBL21356358

SCHEMBL21356358

NC(=O)c1ccc(C(=O)Nc2cccc3cccnc23)cc1O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 7/20 0.64
▸ RAB9A P51151 4/20 0.63
▸ NPC1 O15118 2/20 0.63
▸ CASP3 P42574 1/20 0.63
▸ SENP8 Q96LD8 1/20 0.63
▸ SENP7 Q9BQF6 1/20 0.63
▸ SENP6 Q9GZR1 1/20 0.63
▸ MAPT P10636 5/20 0.63
▸ LMNA P02545 2/20 0.63
▸ HDAC6 Q9UBN7 1/20 0.62
▸ L3MBTL1 Q9Y468 3/20 0.61
▸ MEN1 O00255 2/20 0.61
▸ KMT2A Q03164 2/20 0.61
▸ GAA P10253 2/20 0.60
▸ TDP1 Q9NUW8 1/20 0.60
▸ TP53 P04637 2/20 0.60
▸ KDM4E B2RXH2 1/20 0.58
▸ ALDH1A1 P00352 1/20 0.58
▸ HPGD P15428 1/20 0.58
▸ HTT P42858 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21356103 0.84 KDR (0.65) KDRRAB9ANPC1CASP3SENP8
SCHEMBL28870716 0.83 HDAC6 (0.77) KDRRAB9ANPC1CASP3SENP8
SCHEMBL21356316 0.81 ADORA2A (0.54) HDAC6
SCHEMBL29647697 0.80 HDAC6 (0.84) KDRRAB9ANPC1CASP3SENP8
SCHEMBL19631274 0.80 HDAC6 (0.84) KDRRAB9ANPC1CASP3SENP8
SCHEMBL28302610 0.80 KDR (0.74) KDRRAB9ANPC1CASP3SENP8
SCHEMBL12521447 0.79 KDR (0.71) KDRRAB9ANPC1MAPTHDAC6
SCHEMBL15093487 0.78 HDAC6 (0.77) KDRRAB9ANPC1CASP3SENP8
SCHEMBL27782309 0.78 L3MBTL1 (0.80) KDRRAB9ANPC1MAPTHDAC6
SCHEMBL27803928 0.78 KDR (0.74) KDRRAB9ANPC1MAPTHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11427544-B2 Histone deacetylase 6 inhibitors and use thereof TAIPEI MEDICAL UNIVERSITY (TW) 2022-08-30 — — US disclosed
EP-3458444-B1 HISTONE DEACETYLASE 6 INHIBITORS AND USE THEREOF UNIV TAIPEI MEDICAL (TW) 2022-06-22 — — EP disclosed
US-20190284141-A1 HISTONE DEACETYLASE 6 INHIBITORS AND USE THEREOF DCB-USA LLC (US) 2019-09-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190284141-A1 HISTONE DEACETYLASE 6 INHIBITORS AND USE THEREOF HDAC1, HDAC11, HDAC7 KDR 4795/4885RAB9A 3537/4885NPC1 791/4885
US-11427544-B2 Histone deacetylase 6 inhibitors and use thereof HDAC1, HDAC11, HDAC7 KDR 4795/4885RAB9A 3537/4885NPC1 791/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback